Adoptive T cell transfer augments IL-2 mediated tumour regression in a HNSCC xenograft nude mouse model

Cancer Lett. 2008 Dec 18;272(2):316-24. doi: 10.1016/j.canlet.2008.07.023. Epub 2008 Aug 31.

Abstract

The potential of cytokine gene therapy using naked plasmid DNA encoding human IL-2 cDNA in a xenograft nude mouse model was investigated. To overcome the T cell deficiency in nude mice, Adoptive T Cell Transfer [ATCT] into tumour bearing nude mice was performed. The migration of T cells was tracked in vivo using CFSE labeling. IL-2 in circulation was observed till day 15 with the levels reaching a peak by day 3. Significant activation of transferred T cells (CD69+, CD25+) as well as significant increase in levels of NK cells (CD49b+) was seen in animals receiving IL-2. Tumour regression was observed in the IL-2+ ATCT group.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adoptive Transfer*
  • Animals
  • Carcinoma, Squamous Cell / immunology
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / therapy*
  • Disease Models, Animal
  • Female
  • Flow Cytometry
  • Head and Neck Neoplasms / immunology
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / therapy*
  • Humans
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / therapeutic use*
  • Lymphocyte Activation
  • Mice
  • Mice, Nude
  • Plasmids
  • T-Lymphocytes / transplantation*
  • Transplantation, Heterologous

Substances

  • Interleukin-2